Kingworld Medicines Group Ltd. (HK:1110) has released an update.
Kingworld Medicines Group Ltd. has announced the appointment of Dr. Chu Xiaoping as an independent non-executive Director, effective from September 1, 2024. Dr. Chu brings a wealth of experience with his background in corporate advisory and academia, having held various professorial and directorial roles at prestigious institutions and companies. This strategic addition aims to enhance the Board’s diversity in accordance with the Company’s corporate strategy and policies.
For further insights into HK:1110 stock, check out TipRanks’ Stock Analysis page.
